Global regulatory authorities reaffirm labelling as a high-impact tool to combat antimicrobial resistance

At the Second Global Regulatory Authorities Summit on AMR (14–15 January 2026), global regulatory leaders convened under the Quadripartite Joint Secretariat on AMR to underscore antimicrobial labelling as a practical, low-cost, high-impact intervention within a One Health framework, promoting appropriate use and safe disposal of antimicrobials across human, animal and environmental sectors. Participants — including regulators from over 200 agencies and international partners — agreed that clear, enforceable labelling with actionable information on indications, dosage, side effects, storage and disposal can translate political commitments into real-world impact, guide user behaviour, reduce environmental pollution and strengthen regulatory systems, while emphasizing cross-sector collaboration, phased implementation, capacity-appropriate approaches and tools like local languages, pictograms and digital e-labelling to enhance effectiveness.